F2 and breast cancer: In invasive, basal-like breast cancer cells, such as MDA-MB-231, SCP2 and SUM-159-PT, BCAR3 antagonizes several of TGFβ’s proinvasive effects, such as cell migration, formation of filopodia-like structures and digestion of gelatin matrix.